FORM OF AMENDMENT, WAIVER AND PURCHASE AGREEMENTAmendment, Waiver and Purchase Agreement • May 31st, 2022 • Rapid Therapeutic Science Laboratories, Inc. • Pharmaceutical preparations • New York
This Amendment, Waiver and Purchase Agreement (this “Agreement”) is made and entered into as of May 31, 2022 (the “Effective Date”) by and between Rapid Therapeutic Science Laboratories, Inc. (the “Company”) and ________________ (the “Purchaser” and together with the Company, the “Parties”) for the purpose of, among other things, (i) amending that certain Original Issue Discount Convertible Debenture due May 1, 2022 (the “Original Debenture”), (ii) amending that certain Common Stock Purchase Warrant to purchase 194,118 shares of Common Stock (after giving effect to the 1-for-25 reverse split on March 31, 2022) issued to the Purchaser (the “Original Warrant”), (iii) waiving any and all prior and currently existing events of default under the Original Debenture as of the date hereof, and (iv) agreeing to the purchase and sale of a new Original Issue Discount Convertible Debenture (in the form attached as Exhibit A hereto, the “New Debenture”) and common stock purchase warrant to purchase
